18410 Federal Register / Vol. 61, No. 81 / Thursday, April 25, 1996 / Notices

the following has become a member of

IPACT–II: Northern Healthcare Limited

Harlow, Essex, England. The Restated

Formation Agreement become effective

on May 8, 1995, and supersedes the

prior agreement under which the

Consortium operated. The only

significant change in IPACT–II created

by the new Agreement is that

membership in IPACT–II is now open to

any party that (1) has a commercial

interest in pharmaceutical aerosols and

(2) undertakes to pay its share of

IPACT–II costs.

No other changes have been made in

either the membership or planned

activity of IPACT–II. Membership in

this group research project is open, and

IPACT–II intends to file additional

written notification disclosing all

changes in membership.

On February 21, 1991, IPACT–II filed

its original notification pursuant to

Section 6(a) of the Act. The Department

of Justice published a notice in the

Federal Register pursuant to Section

6(b) of the Act on April 2, 1991 (56

13489).

The last notification was filed with

the Department on January 14, 1993. A

notice was published in the Federal

Register pursuant to Section 6(b) of the

Act on April 27, 1993 (58 FR 25657).

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 96–10264 Filed 4–24–96; 8:45 am]

BILLING CODE 4410–01–M

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993—International

Pharmaceutical Aerosol Consortium

for Toxicology Testing of HFA–134a

(IPACT–I)

Notice is hereby given that, on May

25, 1995, pursuant to Section 6(a) of the

National Cooperative Research and

Production Act of 1993, 15 U.S.C.

§ 4301 et seq. (‘‘the Act’’), The

International Pharmaceutical Aerosol

Consortium for Toxicology Testing of

HFA–134a (‘‘IPACT–I’’) has filed

written notifications simultaneously

with the Attorney General and the

Federal Trade Commission disclosing

(1) a Restated IPACT–I Formation

Agreement and (2) the addition of a new

member. The notifications were filed for

the purpose of extending the Act’s

provisions limiting the recovery of

antitrust plaintiffs to actual damages

under specified circumstances.

Specifically, the following has become a

new member to the IPACT–I: TAP

Holdings, Inc., Deerfield, IL. The

Restated Formation Agreement became

effective on May 8, 1995, and

supersedes the prior agreement under

which the Consortium operated. The

only significant change created by the

new Agreement is that membership in

IPACT–I is now open to any party that:

(1) has a commercial interest in

pharmaceutical aerosols, and (2)

undertakes to pay its share of IPACT–I

costs.

No other changes have been made in

either the membership or planned

activity of IPACT–I. Membership in this

group research project remains open,

and IPACT–I intends to file additional

written notification disclosing all

changes in membership.

On August 7, 1990, IPACT–I filed its

original notification pursuant to Section

6(a) of the Act. The Department of

Justice published a notice in the Federal

Register pursuant to Section 6(b) of the

Act on September 6, 1990 (55 Fed. Reg.

36710).

The last notification was filed with

the Department on January 14, 1993. A

notice was published in the Federal

Register pursuant to Section 6(b) of the

Act on April 27, 1993 (58 FR 25657).

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 96–10265 Filed 4–24–96; 8:45 am]

BILLING CODE 4410–01–M

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993; Industrial Macromolecular

Crystallography Association (‘‘IMCA’’)

Notice is hereby given that on April

8, 1996, pursuant to Section 6(a) of the

National Cooperative Research and

Production Act of 1993, 15 U.S.C.

§ 4301 et seq. (‘‘the Act’’), Industrial

Macromolecular Crystallography

Association (IMCA) has filed written

notifications simultaneously with the

Attorney General and the Federal Trade

Commission disclosing changes in its

membership status. The notifications

were filed for the purpose of extending

the Act’s provisions limiting the

recovery of antitrust plaintiffs to actual

damages under specified circumstances.

Specifically, Sanofi Winthrop, Inc., New

York, NY, has withdrawn as a member

and Schering-Plough Research Institute,

a corporation of Delaware, with its

principal place of business in

Kenilworth, NJ, has become a member.

In addition, two members have changed

their legal names: Glaxo, Inc., has

changed its name to Glaxo Wellcome,

Inc., Research Triangle Park, NC and

Miles, Inc., has changed its name to

Bayer Corporation, Pittsburgh, PA.

No other changes have been made in

either the membership or planned

activity of the group research project.

Membership in this group research

project remains open, and IMCA intends

to file additional written notification

disclosing all changes in membership.

On October 23, 1990, IMCA filed its

original notification pursuant to Section

6(a) of the Act. The Department of

Justice published a notice in the Federal

Register pursuant to Section 6(b) of the

Act on December 3, 1990 (55 FR 49953).

The last notification was filed with

the Department on January 19, 1995. A

notice was published in the Federal

Register pursuant to Section 6(b) of the

Act on December 21, 1995 (60 FR

66324).

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 96–10266 Filed 4–24–96; 8:45 am]

BILLING CODE 4410–01–M

Federal Bureau of Investigation

Criminal Justice Information Services

(CJIS) Advisory Policy Board

The Criminal Justice information

Services (CJIS) Advisory Policy Board

will meet on June 12–13, 1996, from 9

a.m. until 5 p.m., at the Holiday Inn

Downtown/Riverfront, 200 North Fourth

Street, St. Louis, Missouri, telephone

314–621–8200, to formulate

recommendations to the Director,

Federal Bureau of Investigation (FBI) on

the security, policy and operation of the

National Crime Information Center

(NCIC), NCIC 2000, the Integrated

Automated Fingerprint Identification

System (IAFIS), and the Uniform Crime

Reporting (UCR) and National Incident

Based Reporting System (NIBRS)

programs.

The topics to be discussed will

include the progress of the NCIC 2000

and IAFIS projects, status of the Brady

Handgun Violence Prevention Act, and

other topics related to the management

of the FBI’s criminal history information

systems.

The meeting will be open to the

public on a first-come, first-seated basis.

Any member of the public may file a

written statement concerning the FBI

CJIS Division programs or related

matters with the Board, before or after.

Anyone wishing to address this session

of the meeting should notify the

Designated Federal Employee, at least

24 hours prior to the start of the session.

The notification may be by mail,

telegram, cable, facsimile, or a handdelivered note. It should contain the

requestor’s name; corporate designation,

consumer affiliation, or Government

designation; along with a short

statement describing the topic to be

addressed; and the time needed for
Federal Register / Vol. 61, No. 81 / Thursday, April 25, 1996 / Notices 18411

presentation. A nonmember requestor

will ordinarily be allowed not more

than 15 minutes to present a topic,

unless specifically approved by the

Chairman of the Board.

Inquiries may be addressed to the

Designated Federal Employee, Mr.

Demery R. Bishop, Section Chief,

Programs Development Section, CJIS

Division, FBI, 935 Pennsylvania

Avenue, Northwest, Washington, DC

20537–9700, telephone 202–324–5084,

facsimile 202–324–8906.

Demery R. Bishop,

Section Chief, Programs Development

Section, Federal Bureau of Investigation,

Designated Federal Employee.

[FR Doc. 96–10149 Filed 4–24–96; 8:45 am]

BILLING CODE 4410–02–M

Office of Justice Programs

National Institute of Justice

[OJP (NIJ) No.1077]

RIN 1121–ZA32

National Institute of Justice Reissue of

a Solicitation for an Assessment of the

HIDTA Program: High Intensity Drug

Trafficking Areas

AGENCY: U.S. Department of Justice,

Office of Justice Programs, National

Institute of Justice.

ACTION: Announcement of the

availability of the National Institute of

Justice Reissue of a Solicitation for an

Assessment of the HIDTA Program:

High Intensity Drug Trafficking Areas.

ADDRESSES: National Institute of Justice,

633 Indiana Avenue, NW., Washington,

D.C. 20531.

DATES: The deadline for receipt of

proposals is close of business on June 4,

1996.

FOR FURTHER INFORMATION CONTACT:

James Trudeau at (202) 307–1355,

National Institute of Justice, 633 Indiana

Avenue, NW., Washington, DC 20531.

SUPPLEMENTARY INFORMATION: The

following supplementary information is

provided:

Authority

This action is authorized under the

Omnibus Crime Control and Safe Streets

Act of 1968, sections 201–203, as

amended, 42 U.S.C. 3721–3723 (1988).

Background

High Intensity Drug Trafficking Areas

(HIDTA’s) are areas identified as having

the most critical drug trafficking

problems that adversely impact the rest

of the country. The Director of the

Office of National Drug Control Policy

designates areas as HIDTA’s pursuant to

the Anti-Drug Abuse Act of 1988, as

amended. In 1990, five areas were

designated as HIDTA’s—Houston, Los

Angeles, Miami, New York City, and the

Southwest Border, which extends from

California through Texas.

The National Institute of Justice is

soliciting proposals to conduct an

assessment of the HIDTA program in the

five original sites. Funding for this

award is tentatively set at $200,000.

Interested organizations should call the

National Criminal Justice Reference

Service (NCJRS) at 1–800–851–3420 to

obtain a copy of ‘‘National Institute of

Justice Solicitation for an Evaluation of

the HIDTA Program: High Intensity

Drug Trafficking Areas’’ (refer to

document no. SL000143). The

solicitation is available electronically

via the NCJRS Bulletin Board, which

can be accessed via Internet. Telnet to

ncjrsbbs.aspensys.com, or gopher to

ncjrs.aspensys.com 71. For World Wide

Web access, connect to the NCJRS

Justice Information Center at http://

www.ncjrs.org. Those without Internet

access can dial the NCJRS Bulletin

Board via modem: dial 301–738–8895.

Set modem at 9600 baud, 8–N–1.

Jeremy Travis,

Director, National Institute of Justice.

[FR Doc. 96–10272 Filed 4–24–96; 8:45 am]

BILLING CODE 4410–18–P

Lodging of Consent Decree Pursuant

to the Resource Conservation and

Recovery Act

In accordance with Departmental

policy, 28 CFR 50.7, notice is hereby

given that on April 5, 1996 a proposed

consent decree in United States of

America v. Cambridge Plating

Company, Inc., Civil Action No. 96–

10722 RCL, has been lodged with the

United States District Court for the

District of Massachusetts. The United

States’ complaint, filed at the same time

as the consent decree, sought penalties

and injunctive relief under the

Resources Conservation and Recovery

Act, 42 U.S.C. § 6901, et seq. The

consent decree provides that the

defendant will pay $40,000 in civil

penalties to the United States over three

and one half years and also provides for

injunctive relief. The decree further

requires defendant to perform two

Supplemental Environmental Projects.

The Department of Justice will receive

comments relating to the proposed

consent decree for a period of thirty (30)

days from the date of this publication.

Comment should be addressed to the

Assistant Attorney General,

Environment and Natural Resources

Division, Department of Justice,

Washington, D.C. 20530, and should

refer to United States v. Cambridge

Plating Company, Inc., D. J. Ref. 90–7–

1–680A.

The proposed consent decree may be

examined at the office of the United

States Attorney, 1107 John W.

McCormack Federal Building, U.S. Post

Office and Courthouse, Boston, Ma.

02109 and at the Region I office of the

Environmental Protection Agency, One

Congress St., Boston, Ma. 02203. The

proposed consent decree may also be

examined at the Consent Decree Library,

1120 G St., N.W., 4th Floor,

Washington, D.C. 20005, 202–624–0892.

A copy of the proposed consent decree

may be obtained in person or by mail

from the Consent Library, 1120 G St.,

N.W., 4th Floor, Washington, D.C.

20005. In requesting a copy, please

enclose a check in the amount of $8.00

(25 cents per page reproduction cost)

payable to the ‘‘Consent Decree

Library.’’

Joel M. Gross,

Chief, Environmental Enforcement Section,

Environment & Natural Resources Division.

[FR Doc. 96–10153 Filed 4–24–96; 8:45 am]

BILLING CODE 4410–01–M

Notice of Consent Decree in

Comprehensive Environmental

Response, Compensation and Liability

Action

In accordance with the Department

Policy, 28 CFR § 50.7, notice is hereby

given that a Consent Decree in United

States v. Keystone Sanitation Company,

Inc., et al., Civil Action No. 1: CV–93–

1482, was lodged with the United States

District Court for the Middle District of

Pennsylvania on April 5, 1996.

On September 27, 1993, the United

States filed a complaint against the

owners and operator of, and certain

generators to, the Keystone Landfill

Superfund Site (the ‘‘Site’’), pursuant to

Section 107 (a) of the Comprehensive

Environmental Response, Compensation

and Liability Act (CERCLA), 42 U.S.C.

9607(a). Several of the defendants

named third and fourth parties to the

action, including 97 of the defendants in

the proposed Consent Decree. This de

micromis Consent Decree resolves the

liability of the 97 third and fourth-party

defendants for the response costs

incurred and to be incurred by the

United States at the Site. The

defendants included in the proposed de

micromis Consent Decree will pay $1

each.

The Department of Justice will accept

written comments relating to the

proposed Consent Decree for thirty (30)